| Complete response | |||||
---|---|---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | ||||
 | OR | 95% CI | P value | OR | 95% CI | P value |
Age (years) | 1.01 | 0.99–1.04 | 0.286 |  |  |  |
Body mass index (kg/m2) | 1.19 | 1.01–1.39 | 0.037 | 1.27 | 1.04–1.55 | 0.020 |
Serum creatinine (μmol/l) | 0.97 | 0.95–0.99 | 0.001 | 0.99 | 0.97–1.02 | 0.573 |
Tumor stage (IIA2 vs. IB2) | 1.60 | 1.12–2.30 | 0.010 | 0.99 | 0.73–1.35 | 0.956 |
Histology (non-squamous vs. squamous) | 1.55 | 0.64–3.71 | 0.329 |  |  |  |
Tumor differentiation (G3 vs. G1–2) | 0.91 | 0.45–1.84 | 0.784 |  |  |  |
Diabetes | ||||||
 No | Reference | Reference | Reference | Reference | Reference | Reference |
 HbA1c < 7% | 0.05 | 0.02–0.14 | <0.0001 | 0.06 | 0.02–0.17 | <0.0001 |
 HbA1c ≥ 7% | 0.04 | 0.02–0.10 | <0.0001 | 0.04 | 0.02–0.11 | <0.0001 |
 Hypertension (yes vs. no) | 0.34 | 0.20–0.59 | <0.0001 | 0.38 | 0.20–0.74 | 0.004 |
 Cardiovascular disease (yes vs. no) | 0.84 | 0.35–2.04 | 0.700 |  |  |  |
 Metformin (yes vs. no) | 0.64 | 0.34–1.22 | 0.174 |  |  |  |